EU Regulators Team Up With US and UK on Pharmaceutical Mergers

BRUSSELS (Reuters) – EU antitrust enforcers have teamed up with their U.S. and British counterparts to share expertise on how to examine mergers in the pharmaceutical industry amid concerns such deals could push up prices or hold back innovation. The COVID-19 pandemic and vaccine supply bottlenecks have spurred regulatory interest in the pharmaceutical industry which has seen a wave of […]
Continue reading »